Gemget 200mg Injection (Gemcitabine Vials) 200mg

Gemget 200mg Injection contains Gemcitabine, a chemotherapy medication used for cancer treatment. This sterile vial delivers 200mg of active ingredient for intravenous use. Suitable for patients requiring antineoplastic therapy under medical supervision.

Strength

200mg

Pack Size

Storage

Ambient

Manufacturer / TM Owner

GLS Pharma

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Gemcitabine is primarily used to treat various types of cancer including pancreatic, lung, and bladder cancers. It may also be prescribed for certain breast cancers and soft tissue sarcomas. Patients often ask what is Gemcitabine 200mg used for in chemotherapy protocols. The medication works by interfering with cancer cell growth.

Side Effects

Gemcitabine typically causes mild to moderate effects that may include fatigue, nausea, or flu-like symptoms. Some patients report temporary hair thinning or changes in appetite during treatment. These effects vary based on individual response and treatment duration.

Precautions & Warnings

This medication should only be handled by healthcare professionals in controlled settings. Patients must report any unusual bleeding, infections, or breathing difficulties immediately. Regular blood tests are typically required during treatment to monitor safety.

Avoid Interactions

Gemcitabine may interact with other chemotherapy drugs or medications affecting the liver. Alcohol consumption should be avoided during treatment. Patients should inform their doctor about all prescription, over-the-counter, and herbal products they are using.

Frequently Asked Questions

This injection is given intravenously by healthcare professionals in a clinical setting. The administration schedule depends on the specific treatment protocol.

Common effects may include fatigue, nausea, or flu-like symptoms. These typically resolve after treatment completion.

No, this medication requires professional administration in a healthcare facility due to its specialized nature.

No, this medication is prescribed for specific cancer types based on medical evaluation and treatment guidelines.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.